Xellera Therapeutics employs in-process testing to ensure strict quality control across the manufacturing lifecycle. Continuous real-time monitoring and actionable insights minimize variability, improve process consistency, and reinforce Quality by Design (QbD)—delivering safe, scalable, and compliant cell and gene therapy products within a robust cGMP framework. https://ext-6783855.livejournal.com/267.html